Blue Capital’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$313K Sell
843
-275
-25% -$97.1K 0.19% 103
2026
Q2
$401K Buy
+1,118
New +$342K 0.25% 78

Other funds holding WST

Blue Capital's WST Position: Q3 2026 in Review

Blue Capital reduced its West Pharmaceutical (WST) stake by 25% in Q3 2026, selling an estimated $97.1K and leaving 843 shares worth $313K. The position accounts for 0.19% of the portfolio, ranked #103.

Blue Capital first reported a position in WST in Q2 2026 and has held it in 2 quarters since. The position peaked at $401K in Q2 2026. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Blue Capital held 843 shares of West Pharmaceutical worth $313K as of Q3 2026.
  • Blue Capital sold 275 West Pharmaceutical shares in Q3 2026, an estimated $97.1K.
  • West Pharmaceutical made up 0.19% of Blue Capital's portfolio in Q3 2026, its #103 holding.
  • Blue Capital first reported a position in West Pharmaceutical in Q2 2026 and has held it in 2 quarters since.
  • Blue Capital's West Pharmaceutical position peaked at $401K in Q2 2026.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Blue Capital's 13F filing for Q3 2026, filed 13 Oct 2026.